vs

Side-by-side financial comparison of Element Solutions Inc (ESI) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $840.0M, roughly 1.8× Element Solutions Inc). Element Solutions Inc runs the higher net margin — 6.7% vs 4.4%, a 2.2% gap on every dollar of revenue. On growth, Element Solutions Inc posted the faster year-over-year revenue change (41.0% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-74.2M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 17.1%).

Element Solutions Inc is an American specialty chemicals production corporation listed on the New York Stock Exchange.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

ESI vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.8× larger
ONC
$1.5B
$840.0M
ESI
Growing faster (revenue YoY)
ESI
ESI
+8.2% gap
ESI
41.0%
32.8%
ONC
Higher net margin
ESI
ESI
2.2% more per $
ESI
6.7%
4.4%
ONC
More free cash flow
ONC
ONC
$454.0M more FCF
ONC
$379.8M
$-74.2M
ESI
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
17.1%
ESI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ESI
ESI
ONC
ONC
Revenue
$840.0M
$1.5B
Net Profit
$56.0M
$66.5M
Gross Margin
38.4%
90.5%
Operating Margin
13.3%
12.4%
Net Margin
6.7%
4.4%
Revenue YoY
41.0%
32.8%
Net Profit YoY
-43.0%
143.8%
EPS (diluted)
$0.23
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESI
ESI
ONC
ONC
Q1 26
$840.0M
Q4 25
$676.2M
$1.5B
Q3 25
$656.1M
$1.4B
Q2 25
$625.2M
$1.3B
Q1 25
$593.7M
$1.1B
Q4 24
$624.2M
$1.1B
Q3 24
$645.0M
$1.0B
Q2 24
$612.7M
$929.2M
Net Profit
ESI
ESI
ONC
ONC
Q1 26
$56.0M
Q4 25
$6.2M
$66.5M
Q3 25
$39.3M
$124.8M
Q2 25
$47.4M
$94.3M
Q1 25
$98.0M
$1.3M
Q4 24
$54.7M
$-151.9M
Q3 24
$40.3M
$-121.3M
Q2 24
$93.2M
$-120.4M
Gross Margin
ESI
ESI
ONC
ONC
Q1 26
38.4%
Q4 25
40.9%
90.5%
Q3 25
42.2%
86.1%
Q2 25
42.6%
87.5%
Q1 25
42.2%
85.2%
Q4 24
41.0%
85.8%
Q3 24
41.5%
83.0%
Q2 24
43.6%
85.1%
Operating Margin
ESI
ESI
ONC
ONC
Q1 26
13.3%
Q4 25
10.3%
12.4%
Q3 25
15.4%
11.5%
Q2 25
15.1%
6.7%
Q1 25
13.0%
1.0%
Q4 24
12.0%
-7.0%
Q3 24
14.7%
-12.0%
Q2 24
15.7%
-11.5%
Net Margin
ESI
ESI
ONC
ONC
Q1 26
6.7%
Q4 25
0.9%
4.4%
Q3 25
6.0%
8.8%
Q2 25
7.6%
7.2%
Q1 25
16.5%
0.1%
Q4 24
8.8%
-13.5%
Q3 24
6.2%
-12.1%
Q2 24
15.2%
-13.0%
EPS (diluted)
ESI
ESI
ONC
ONC
Q1 26
$0.23
Q4 25
$0.03
$0.05
Q3 25
$0.16
$0.08
Q2 25
$0.20
$0.06
Q1 25
$0.40
$0.00
Q4 24
$0.22
$-0.10
Q3 24
$0.17
$-0.09
Q2 24
$0.39
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESI
ESI
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$177.3M
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$2.7B
$4.4B
Total Assets
$5.7B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESI
ESI
ONC
ONC
Q1 26
$177.3M
Q4 25
$626.5M
$4.5B
Q3 25
$594.3M
$4.0B
Q2 25
$529.9M
$2.8B
Q1 25
$499.2M
$2.5B
Q4 24
$359.4M
$2.6B
Q3 24
$376.0M
$2.7B
Q2 24
$309.3M
$2.6B
Total Debt
ESI
ESI
ONC
ONC
Q1 26
Q4 25
$1.6B
$836.4M
Q3 25
$1.6B
Q2 25
$1.6B
Q1 25
$1.6B
Q4 24
$1.8B
Q3 24
$1.9B
Q2 24
$1.9B
Stockholders' Equity
ESI
ESI
ONC
ONC
Q1 26
$2.7B
Q4 25
$2.7B
$4.4B
Q3 25
$2.7B
$4.1B
Q2 25
$2.6B
$3.8B
Q1 25
$2.5B
$3.5B
Q4 24
$2.4B
$3.3B
Q3 24
$2.4B
$3.4B
Q2 24
$2.4B
$3.4B
Total Assets
ESI
ESI
ONC
ONC
Q1 26
$5.7B
Q4 25
$5.1B
$8.2B
Q3 25
$5.0B
$7.6B
Q2 25
$5.0B
$6.3B
Q1 25
$4.8B
$5.8B
Q4 24
$4.9B
$5.9B
Q3 24
$5.1B
$5.8B
Q2 24
$5.0B
$5.7B
Debt / Equity
ESI
ESI
ONC
ONC
Q1 26
Q4 25
0.61×
0.19×
Q3 25
0.61×
Q2 25
0.62×
Q1 25
0.64×
Q4 24
0.76×
Q3 24
0.78×
Q2 24
0.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESI
ESI
ONC
ONC
Operating Cash FlowLast quarter
$417.3M
Free Cash FlowOCF − Capex
$-74.2M
$379.8M
FCF MarginFCF / Revenue
-8.8%
25.4%
Capex IntensityCapex / Revenue
3.0%
2.5%
Cash ConversionOCF / Net Profit
6.28×
TTM Free Cash FlowTrailing 4 quarters
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESI
ESI
ONC
ONC
Q1 26
Q4 25
$417.3M
Q3 25
$100.1M
$402.6M
Q2 25
$263.6M
Q1 25
$26.0M
$44.1M
Q4 24
$75.2M
Q3 24
$98.5M
$188.4M
Q2 24
$-95.6M
Free Cash Flow
ESI
ESI
ONC
ONC
Q1 26
$-74.2M
Q4 25
$379.8M
Q3 25
$83.6M
$354.5M
Q2 25
$219.8M
Q1 25
$15.0M
$-12.3M
Q4 24
$-17.3M
Q3 24
$85.9M
$54.7M
Q2 24
$-205.5M
FCF Margin
ESI
ESI
ONC
ONC
Q1 26
-8.8%
Q4 25
25.4%
Q3 25
12.7%
25.1%
Q2 25
16.7%
Q1 25
2.5%
-1.1%
Q4 24
-1.5%
Q3 24
13.3%
5.5%
Q2 24
-22.1%
Capex Intensity
ESI
ESI
ONC
ONC
Q1 26
3.0%
Q4 25
2.5%
2.5%
Q3 25
2.5%
3.4%
Q2 25
2.8%
3.3%
Q1 25
1.9%
5.0%
Q4 24
3.6%
8.2%
Q3 24
2.0%
13.3%
Q2 24
2.4%
11.8%
Cash Conversion
ESI
ESI
ONC
ONC
Q1 26
Q4 25
6.28×
Q3 25
2.55×
3.22×
Q2 25
2.79×
Q1 25
0.27×
34.71×
Q4 24
Q3 24
2.44×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESI
ESI

Electronics ex-Metals$377.8M45%
Pass-through Metals$255.7M30%
Other$206.5M25%

ONC
ONC

Segment breakdown not available.

Related Comparisons